JP2024156964A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2024156964A5 JP2024156964A5 JP2024133744A JP2024133744A JP2024156964A5 JP 2024156964 A5 JP2024156964 A5 JP 2024156964A5 JP 2024133744 A JP2024133744 A JP 2024133744A JP 2024133744 A JP2024133744 A JP 2024133744A JP 2024156964 A5 JP2024156964 A5 JP 2024156964A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- kda
- seq
- protein
- set forth
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1807378.3A GB201807378D0 (en) | 2018-05-04 | 2018-05-04 | Vaccine composition |
| GB1807376.7 | 2018-05-04 | ||
| GB1807378.3 | 2018-05-04 | ||
| GBGB1807376.7A GB201807376D0 (en) | 2018-05-04 | 2018-05-04 | HMCV Vaccine Composition |
| PCT/GB2019/051245 WO2019211630A2 (en) | 2018-05-04 | 2019-05-03 | Vaccine composition |
| JP2021510553A JP7575096B2 (ja) | 2018-05-04 | 2019-05-03 | ワクチン組成物 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021510553A Division JP7575096B2 (ja) | 2018-05-04 | 2019-05-03 | ワクチン組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024156964A JP2024156964A (ja) | 2024-11-06 |
| JP2024156964A5 true JP2024156964A5 (enExample) | 2025-01-21 |
Family
ID=66484095
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021510553A Active JP7575096B2 (ja) | 2018-05-04 | 2019-05-03 | ワクチン組成物 |
| JP2024133744A Pending JP2024156964A (ja) | 2018-05-04 | 2024-08-09 | ワクチン組成物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021510553A Active JP7575096B2 (ja) | 2018-05-04 | 2019-05-03 | ワクチン組成物 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US12433944B2 (enExample) |
| EP (1) | EP3787676A2 (enExample) |
| JP (2) | JP7575096B2 (enExample) |
| KR (1) | KR20210013571A (enExample) |
| CN (2) | CN120040601A (enExample) |
| AU (2) | AU2019263706B2 (enExample) |
| BR (1) | BR112020022393A2 (enExample) |
| CA (1) | CA3099381A1 (enExample) |
| IL (1) | IL278418B2 (enExample) |
| SG (1) | SG11202010821TA (enExample) |
| WO (1) | WO2019211630A2 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019211630A2 (en) * | 2018-05-04 | 2019-11-07 | SpyBiotech Limited | Vaccine composition |
| GB201917265D0 (en) * | 2019-11-27 | 2020-01-08 | Univ Sheffield | Bonded neurotoxins |
| JP7801221B2 (ja) * | 2019-12-11 | 2026-01-16 | ザ ユナイテッド ステイツ オブ アメリカ アズ リプリゼンテッド バイ ザ セクレタリー、デパートメント オブ ヘルス アンド ヒューマン サービシーズ | 流行性耳下腺炎ウイルスおよび麻疹ウイルスの免疫原およびそれらの使用 |
| CN114634578B (zh) * | 2020-12-15 | 2024-04-02 | 榕森生物科技(北京)有限公司 | 针对新型冠状病毒感染的疫苗组合物 |
| MX2023007319A (es) * | 2020-12-18 | 2023-08-08 | Univ Copenhagen | Vacunas de acido nucleico. |
| US20240240203A1 (en) * | 2021-05-04 | 2024-07-18 | SpyBiotech Limited | Adenoviral vectors and vaccines thereof |
| CN114736272B (zh) * | 2022-02-21 | 2022-09-06 | 悦康药业集团股份有限公司 | 一种优化病毒膜融合抑制剂的方法及广谱抗冠状病毒脂肽和应用 |
| CN115920026B (zh) * | 2022-04-02 | 2023-11-14 | 中山大学 | 耐热性多聚体蛋白支架、耐热性多聚体蛋白支架在疫苗中的应用 |
| CN115010812B (zh) * | 2022-04-12 | 2024-06-21 | 河南省龙星生物科技有限公司 | 一种非洲猪瘟抗原介导细胞免疫的多聚体及应用 |
| CN116041536A (zh) * | 2022-09-15 | 2023-05-02 | 山西大学 | 一种多接头自组装蛋白纳米颗粒的制备方法与应用 |
| CN117462666B (zh) * | 2022-09-30 | 2024-07-30 | 烟台派诺生物技术有限公司 | 一种预防或治疗水痘-带状疱疹病毒相关疾病的免疫组合物产品及其制备方法 |
| CN117264074A (zh) * | 2023-01-12 | 2023-12-22 | 东沃同泰(凤城)生物工程有限公司 | 靶向DCs递送的耐热性纳米颗粒蛋白、纳米载体、免疫原性复合物和纳米颗粒疫苗及应用 |
| CN117050149B (zh) * | 2023-05-19 | 2025-12-12 | 珠海丽凡达生物技术有限公司 | 包含人呼吸道合胞病毒抗原的免疫组合物及其制备方法和应用 |
| CN117264081B (zh) * | 2023-11-21 | 2025-03-21 | 华南理工大学 | 一种双肽受体激动剂及其制备方法与应用 |
| CN118373888B (zh) * | 2024-06-27 | 2024-08-30 | 普大生物科技(泰州)有限公司 | 一种水痘-带状疱疹病毒纳米颗粒蛋白及其制备方法和应用 |
| WO2026028158A1 (en) * | 2024-07-31 | 2026-02-05 | Biohaven Therapeutics Ltd. | Targeted degradation of anti-aav antibodies to enable aav-based gene therapy |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5474914A (en) | 1992-07-29 | 1995-12-12 | Chiron Corporation | Method of producing secreted CMV glycoprotein H |
| US7951384B2 (en) * | 2005-08-05 | 2011-05-31 | University Of Massachusetts | Virus-like particles as vaccines for paramyxovirus |
| KR101617895B1 (ko) | 2007-12-24 | 2016-05-03 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | 재조합 ｒｓｖ 항원 |
| WO2011009877A1 (de) | 2009-07-24 | 2011-01-27 | Basf Se | Flammgeschützte polyamidformmassen |
| GB201002362D0 (en) | 2010-02-11 | 2010-03-31 | Isis Innovation | Peptide tag systems that spontaneously form an irreversible link to protein partners via isopeptide bonds |
| US20130164289A1 (en) | 2010-09-09 | 2013-06-27 | Virginia Commonwealth University | Human cytomegalovirus vaccine |
| CN107875382B (zh) * | 2011-11-11 | 2024-03-08 | 变异生物技术公司 | 用于治疗巨细胞病毒的组合物和方法 |
| JP2015522581A (ja) | 2012-07-06 | 2015-08-06 | ノバルティス アーゲー | サイトメガロウイルスタンパク質の複合体 |
| PT2970398T (pt) | 2013-03-13 | 2024-06-07 | The Us Secretary Department Ofhealth And Human Servic | Proteínas f de pré-fusão do vsr e sua utilização |
| NZ721908A (en) | 2013-12-20 | 2022-12-23 | Massachusetts Gen Hospital | Combination therapy with neoantigen vaccine |
| EP3015475A1 (en) | 2014-10-31 | 2016-05-04 | Novartis AG | Mammalian cells expressing cytomegalovirus antigens |
| US10526376B2 (en) * | 2015-01-15 | 2020-01-07 | University Of Copenhagen | Virus-like particle with efficient epitope display |
| GB201509782D0 (en) | 2015-06-05 | 2015-07-22 | Isis Innovation | Methods and products for fusion protein synthesis |
| CN115960263A (zh) | 2016-03-29 | 2023-04-14 | 美国政府(由卫生和人类服务部的部长所代表) | 取代修饰的融合前rsv f蛋白及其用途 |
| CN106081304A (zh) | 2016-07-27 | 2016-11-09 | 佛山市高明金荣华乐金属制品有限公司 | 一种新型可折叠箱体及其拆装方法 |
| GB201705750D0 (en) | 2017-04-10 | 2017-05-24 | Univ Oxford Innovation Ltd | Peptide ligase and use therof |
| GB201706430D0 (en) | 2017-04-24 | 2017-06-07 | Univ Oxford Innovation Ltd | Proteins and peptide tags with enhanced rate of spontaneous isopeptide bond formation and uses thereof |
| WO2019211630A2 (en) * | 2018-05-04 | 2019-11-07 | SpyBiotech Limited | Vaccine composition |
-
2019
- 2019-05-03 WO PCT/GB2019/051245 patent/WO2019211630A2/en not_active Ceased
- 2019-05-03 BR BR112020022393-0A patent/BR112020022393A2/pt unknown
- 2019-05-03 IL IL278418A patent/IL278418B2/en unknown
- 2019-05-03 CN CN202510197781.6A patent/CN120040601A/zh active Pending
- 2019-05-03 CA CA3099381A patent/CA3099381A1/en active Pending
- 2019-05-03 KR KR1020207034602A patent/KR20210013571A/ko not_active Ceased
- 2019-05-03 EP EP19723480.0A patent/EP3787676A2/en active Pending
- 2019-05-03 SG SG11202010821TA patent/SG11202010821TA/en unknown
- 2019-05-03 CN CN201980044956.2A patent/CN112638411B/zh active Active
- 2019-05-03 JP JP2021510553A patent/JP7575096B2/ja active Active
- 2019-05-03 US US17/052,707 patent/US12433944B2/en active Active
- 2019-05-03 AU AU2019263706A patent/AU2019263706B2/en active Active
-
2024
- 2024-08-09 JP JP2024133744A patent/JP2024156964A/ja active Pending
-
2025
- 2025-09-09 US US19/323,644 patent/US20260007740A1/en active Pending
-
2026
- 2026-02-12 AU AU2026201020A patent/AU2026201020A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7575096B2 (ja) | ワクチン組成物 | |
| JP7189014B2 (ja) | Ｒｓｖに対するワクチン | |
| AU2007239354B2 (en) | N protein fusion proteins of a virus in the Paramyxoviridae-protein of interest family | |
| JP2023530434A (ja) | コロナウイルスワクチン組成物、方法、及びその使用 | |
| CN112469661A (zh) | 具有新结构组分的纳米粒疫苗 | |
| CN101932594A (zh) | 可用作疫苗的自装配肽纳米颗粒 | |
| JP2013503159A5 (enExample) | ||
| JP2013501038A5 (enExample) | ||
| CN114929877A (zh) | 突变型rsv f蛋白及其利用 | |
| JP2020536489A5 (enExample) | ||
| JP5545209B2 (ja) | 免疫原性を有する物質 | |
| JP7602457B2 (ja) | ペプチド核酸を基盤としたアジュバント | |
| JP2021533772A (ja) | フィロウイルス糖タンパク質の安定化された三量体 | |
| CN113430178A (zh) | 一种表达ii型单纯疱疹病毒蛋白的重组流感病毒株及其制备方法与应用 | |
| Li et al. | Essential sequence of influenza neuraminidase DNA to provide protection against lethal viral infection | |
| WO2002078732A1 (en) | A noval vaccine formulation consisting of dna vaccine inactivated virus | |
| HK40127919A (zh) | 疫苗组合物 | |
| CN114409802B (zh) | 禽流感病毒三聚体亚单位疫苗及其应用 | |
| CN120548366A (zh) | 疫苗 | |
| HK40098178A (zh) | 人偏肺病毒疫苗 | |
| AU2001297689A1 (en) | A noval vaccine formulation consisting of DNA vaccine inactivated virus | |
| ZA200304631B (en) | A novel vaccine formulation consisting of DNA vaccine inactivated virus. |